PMID: 9187265Jun 1, 1997Paper

A dominant negative mutant of the G protein-coupled receptor kinase 2 selectively attenuates adenosine A2 receptor desensitization

Molecular Pharmacology
S J MundellE Kelly

Abstract

G protein-coupled receptor kinases (GRKs) are thought to be important in mediating the agonist-induced phosphorylation and consequent desensitization of G protein-coupled receptor responses. NG108-15 mouse neuroblastoma X rat glioma cells express a wide range of G protein-coupled receptors and significant levels of GRK2. Therefore, to determine the role of GRK2 in agonist-induced desensitization of various G(s)-coupled receptors in NG108-15 cells, we stably transfected cells with a dominant negative mutant GRK2 construct (Lys220Arg). In homogenates prepared from cells overexpressing the dominant negative mutant GRK2, the acute stimulation of adenylyl cyclase by various receptor and nonreceptor agonists was the same as in control cells stably transfected with plasmid only. NG108-15 cells express both A2a and A2b adenosine receptors, which mediate activation of adenylyl cyclase, with both of these responses being subject to agonist-induced desensitization with a t1/2 of 15-20 min. In dominant negative mutant GRK2 cells, the rates of desensitization of A2a and A2b receptor-stimulated adenylyl cyclase were markedly slower than in plasmid transfected controls, with the latter being similar to wild-type cells. After a 20-min treatmen...Continue Reading

References

Dec 1, 1992·Human Molecular Genetics·C AmbroseJ J Wasmuth
Apr 1, 1991·Biochemical Society Transactions·F R McKenzieG Milligan
Nov 1, 1989·Biochemical Pharmacology·M KeenJ MacDermot
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J L BenovicR J Lefkowitz
Jan 1, 1995·Vitamins and Hormones·R Sterne-Marr, J L Benovic
Feb 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R T PremontR J Lefkowitz
Aug 1, 1994·Journal of Neurochemistry·T HagaK Kameyama
Sep 20, 1996·The Journal of Biological Chemistry·M H HoltmannL J Miller

❮ Previous
Next ❯

Citations

Oct 6, 1998·Annual Review of Biochemistry·J A PitcherR J Lefkowitz
May 5, 1999·The Journal of Physiology·M Bünemann, M M Hosey
Mar 15, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·F M DautzenbergR L Hauger
Feb 4, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Kersten M SmallStephen B Liggett
Feb 5, 2008·British Journal of Pharmacology·J Zezula, M Freissmuth
Mar 28, 2008·Purinergic Signalling·Elisabeth C KlaasseMargot W Beukers
Jul 2, 2016·Journal of Neurochemistry·Rodrigo A Cunha
Apr 18, 1998·The Journal of Biological Chemistry·G InnamoratiM Birnbaumer
Apr 1, 1999·Annual Review of Physiology·M BünemannM M Hosey
Oct 1, 2005·Journal of Receptor and Signal Transduction Research·Yuting Tang, Keith T Demarest
Aug 12, 2009·The Journal of Pharmacology and Experimental Therapeutics·Liyun WangStuart Maudsley
Feb 10, 2009·Journal of Neurochemistry·Sofia Cristóvão-FerreiraAna M Sebastião
Jan 31, 2014·International Journal of Molecular Sciences·Sandeep ShethVickram Ramkumar
May 23, 1998·Annual Review of Pharmacology and Toxicology·J G Krupnick, J L Benovic
Dec 5, 1998·The Journal of Biological Chemistry·V BeaumontG Henderson
Jun 3, 2008·Journal of Thrombosis and Haemostasis : JTH·S J MundellA W Poole
Jun 9, 2000·Annual Review of Physiology·W J KochH A Rockman
Jun 11, 2005·The Journal of Biological Chemistry·Thierry J HornerEllen R Weiss
Jun 6, 2000·American Journal of Physiology. Cell Physiology·S V SitaramanJ L Madara
Jun 29, 2006·Molecular Pharmacology·Stuart J MundellAlastair W Poole
Apr 25, 2000·The Journal of Biological Chemistry·S J Mundell, J L Benovic
May 19, 2010·Biochimica Et Biophysica Acta·Simon KeuerleberMichael Freissmuth
Aug 4, 1998·Current Opinion in Neurobiology·C V Carman, J L Benovic
Jan 10, 2002·Cellular Signalling·Markus KlingerChristian Nanoff
Mar 18, 2000·Pharmacology & Therapeutics·M E Olah, G L Stiles
Jul 8, 2008·European Journal of Pharmacology·Frank BrandGunnar Schulte
Jun 17, 2010·Biochimica Et Biophysica Acta·Stuart Mundell, Eamonn Kelly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.